Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Viemed Healthcare (VMD) EBITDA Margin (2018 - 2025)

Viemed Healthcare (VMD) has disclosed EBITDA Margin for 6 consecutive years, with 10.99% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin rose 36.0% year-over-year to 10.99%, compared with a TTM value of 8.49% through Dec 2025, up 78.0%, and an annual FY2025 reading of 8.49%, up 347.0% over the prior year.
  • EBITDA Margin was 10.99% for Q4 2025 at Viemed Healthcare, up from 7.85% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 12.95% in Q4 2021 and bottomed at 3.08% in Q2 2022.
  • Average EBITDA Margin over 5 years is 6.76%, with a median of 6.32% recorded in 2021.
  • The sharpest move saw EBITDA Margin tumbled -3953bps in 2021, then surged 379bps in 2024.
  • Year by year, EBITDA Margin stood at 12.95% in 2021, then plummeted by -51bps to 6.35% in 2022, then increased by 8bps to 6.85% in 2023, then skyrocketed by 55bps to 10.63% in 2024, then grew by 3bps to 10.99% in 2025.
  • Business Quant data shows EBITDA Margin for VMD at 10.99% in Q4 2025, 7.85% in Q3 2025, and 8.08% in Q2 2025.